Ximaract

Ximaract (Cefuroxime) is an antibiotic medication used intracamerally to prevent infections after eye surgery. It belongs to the cephalosporin class and targets bacterial growth. Suitable for post-operative care in ophthalmology. Short-term use only.

Ximaract (Cefuroxime) is used intracamerally to reduce the risk of bacterial infections following cataract surgery or other intraocular procedures. It works by inhibiting bacterial cell wall synthesis, helping to protect the eye during recovery. Often prescribed as a single-dose injection into the anterior chamber. Commonly referred to as what is Ximaract used for in post-surgical care.

After intracameral administration, Ximaract (Cefuroxime) may cause mild eye irritation or redness at the injection site. Some patients report temporary blurred vision or discomfort, which typically resolves quickly. These effects are usually short-lived and part of the body’s response to treatment. No long-term systemic effects are expected with this localized use.

Ximaract (Cefuroxime) should only be handled and administered by a healthcare professional. Patients with known allergies to cephalosporins or penicillins should inform their doctor before use. The injection site must be sterile to prevent contamination. Always follow the prescribed procedure and avoid reuse of any remaining solution.

No significant drug interactions are reported with intracameral Cefuroxime, as it acts locally within the eye. However, concurrent use of systemic antibiotics may increase the risk of resistance. Alcohol consumption is not known to interact with this medication. Always disclose all medications to your healthcare provider before treatment.